BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30087776)

  • 21. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
    Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
    Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sporadic paraganglioma caused by de novo SDHB mutations in a 6-year-old girl.
    Imamura H; Muroya K; Tanaka E; Konomoto T; Moritake H; Sato T; Kimura N; Takekoshi K; Nunoi H
    Eur J Pediatr; 2016 Jan; 175(1):137-41. PubMed ID: 26283294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    De Filpo G; Cilotti A; Rolli L; Pastorino U; Sonzogni A; Pradella S; Cantini G; Ercolino T; Nesi G; Mannelli M; Maggi M; Canu L
    Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33113876
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.
    Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD
    Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
    Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
    Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: beyond pheochromocytomas and paragangliomas.
    Mannelli M; Canu L; Ercolino T; Rapizzi E; Martinelli S; Parenti G; De Filpo G; Nesi G
    Eur J Endocrinol; 2018 Jan; 178(1):R11-R17. PubMed ID: 28924001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of Immunohistochemistry for SDHB in the Screening of Hereditary Pheochromocytoma-Paraganglioma.
    Choi HR; Koo JS; Lee CR; Lee JD; Kang SW; Jo YS; Chung WY
    Biology (Basel); 2021 Jul; 10(7):. PubMed ID: 34356532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening.
    Iacovazzo D; Hernández-Ramírez LC; Korbonits M
    Expert Rev Endocrinol Metab; 2017 Mar; 12(2):143-153. PubMed ID: 30063429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma/paraganglioma.
    Dwight T; Mann K; Benn DE; Robinson BG; McKelvie P; Gill AJ; Winship I; Clifton-Bligh RJ
    J Clin Endocrinol Metab; 2013 Jun; 98(6):E1103-8. PubMed ID: 23633203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a TMEM127 variant in a patient with paraganglioma and acromegaly.
    Stütz B; Korbonits M; Kothbauer K; Müller W; Fischli S
    Endocrinol Diabetes Metab Case Rep; 2020 Sep; 2020():. PubMed ID: 33416299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SDHA is a tumor suppressor gene causing paraganglioma.
    Burnichon N; Brière JJ; Libé R; Vescovo L; Rivière J; Tissier F; Jouanno E; Jeunemaitre X; Bénit P; Tzagoloff A; Rustin P; Bertherat J; Favier J; Gimenez-Roqueplo AP
    Hum Mol Genet; 2010 Aug; 19(15):3011-20. PubMed ID: 20484225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum.
    Niemeijer ND; Papathomas TG; Korpershoek E; de Krijger RR; Oudijk L; Morreau H; Bayley JP; Hes FJ; Jansen JC; Dinjens WN; Corssmit EP
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1386-93. PubMed ID: 26259135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes
    Andrews KA; Ascher DB; Pires DEV; Barnes DR; Vialard L; Casey RT; Bradshaw N; Adlard J; Aylwin S; Brennan P; Brewer C; Cole T; Cook JA; Davidson R; Donaldson A; Fryer A; Greenhalgh L; Hodgson SV; Irving R; Lalloo F; McConachie M; McConnell VPM; Morrison PJ; Murday V; Park SM; Simpson HL; Snape K; Stewart S; Tomkins SE; Wallis Y; Izatt L; Goudie D; Lindsay RS; Perry CG; Woodward ER; Antoniou AC; Maher ER
    J Med Genet; 2018 Jun; 55(6):384-394. PubMed ID: 29386252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects.
    Pepe S; Korbonits M; Iacovazzo D
    J Endocrinol; 2019 Feb; 240(2):R21-R45. PubMed ID: 30530903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and functional consequences of succinate dehydrogenase subunit B mutations.
    Kim E; Rath EM; Tsang VH; Duff AP; Robinson BG; Church WB; Benn DE; Dwight T; Clifton-Bligh RJ
    Endocr Relat Cancer; 2015 Jun; 22(3):387-97. PubMed ID: 25972245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: an update.
    Persu A; Lannoy N; Maiter D; Mendola A; Montigny P; Oriot P; Vinck W; Garin P; Hamoir M; Vikkula M
    Horm Metab Res; 2012 May; 44(5):349-53. PubMed ID: 22566194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of metastatic pheochromocytoma and paraganglioma in
    Lee H; Jeong S; Yu Y; Kang J; Sun H; Rhee JK; Kim YH
    J Med Genet; 2020 Apr; 57(4):217-225. PubMed ID: 31649053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency.
    Richter S; Peitzsch M; Rapizzi E; Lenders JW; Qin N; de Cubas AA; Schiavi F; Rao JU; Beuschlein F; Quinkler M; Timmers HJ; Opocher G; Mannelli M; Pacak K; Robledo M; Eisenhofer G
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3903-11. PubMed ID: 25014000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
    Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
    JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.